Andere Kunden interessierten sich auch für
![Formulation et évaluation d'un gel in-situ de Benzoate de Rizatriptan par QbD]( "Formulation et évaluation d'un gel in-situ de Benzoate de Rizatriptan par QbD")
Formulation et évaluation d'un gel in-situ de Benzoate de Rizatriptan par QbD36,99 €![Formulierung und Bewertung eines In-situ-Gels von Rizatriptan Benzoat durch QbD]( "Formulierung und Bewertung eines In-situ-Gels von Rizatriptan Benzoat durch QbD")
Formulierung und Bewertung eines In-situ-Gels von Rizatriptan Benzoat durch QbD54,90 €![Formulazione e valutazione in-situ gel di Rizatriptan Benzoato da QbD]( "Formulazione e valutazione in-situ gel di Rizatriptan Benzoato da QbD")
Formulazione e valutazione in-situ gel di Rizatriptan Benzoato da QbD36,99 €![Formulação e Avaliação in-situ do Benzoato de Rizatriptan por QbD]( "Formulação e Avaliação in-situ do Benzoato de Rizatriptan por QbD")
Formulação e Avaliação in-situ do Benzoato de Rizatriptan por QbD36,99 €![Orodispersible Tablets Of Rizatriptan Benzoate]( "Orodispersible Tablets Of Rizatriptan Benzoate")
Orodispersible Tablets Of Rizatriptan Benzoate26,99 €![Application of QbD to Powder Compaction]( "Application of QbD to Powder Compaction")
Application of QbD to Powder Compaction36,99 €![Formulation and evaluation of rizatriptan benzoate Orodispersibl table]( "Formulation and evaluation of rizatriptan benzoate Orodispersibl table")
Formulation and evaluation of rizatriptan benzoate Orodispersibl table29,99 €
Chemically Rizatriptan Benzoate is the N, N-diethyl -5(1H-1,2,4-triazol-1-ylmethyl)-1H-indole-3-ethanamine mono benzoate and is a selective 5-hydroxytriptamin[5-HT] 1B/1D receptor agonist. It has a weak affinity for other 5-HT receptor subtype and was launched in 1998 for the acute treatment of migraine in adults. It has good water solubility (42mg/ml) and poor bioavailability [45%] due to hepatic first pass effect. The suggested mechanism of anti-migraine action of Rizatriptan Benzoate is through activation of post synaptic 5-HT 1B receptor within cerebral and Dural vessel walls, causing vasoconstriction of per vascular nerve terminals. The most prominent advantage of in situ gel over the conventional gel is that it's can be easily instilled as a drop allowing accurate drug dosing. The objectives of presented study is to develop in situ gel of Rizatriptan Benzoate, with favourable gelation , viscosity , temperature and released property. This may gives patient friendly, needle free dosage form.